VAX2012Q: Phase II started

VaxInnate began a double-blind, U.S. Phase II trial to compare a single dose of 8 and 12 ug VAX2012Q vs. Fluzone Quadrivalent from Sanofi (Euronext:SAN; NYSE:SNY, Paris, France) in up to 450 healthy...